You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 52 No. 5, May 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Longitudinal Study of Symptom Dimensions in Schizophrenia

Prediction and Patterns of Change

Stephan Arndt, PhD; Nancy C. Andreasen, MD, PhD; Michael Flaum, MD; Del Miller, PharmD, MD; Peg Nopoulos, MD

Arch Gen Psychiatry. 1995;52(5):352-360.


Abstract

Background
Factor analytic studies have suggested that the symptoms of schizophrenia may be divided into three uncorrelated dimensions. This study examines the longitudinal course of the symptoms of schizophrenia using this three-dimensional perspective.

Methods
The sample was composed primarily ofneuroleptic-naive patients suffering from schizophrenia. Subjects were studied in a prospective longitudinal design, with comprehensive structured assessments at index, discharge, and 6-month intervals after discharge over a 2-year period.

Results
Negative symptoms were already relatively prominent at the time of index evaluation; they tended to remain stable throughout the follow-up period. The two dimensions of positive symptoms, psychoticism and disorganization, although prominent at index evaluation, declined over the course of the follow-up period and tended to be less stable. A longitudinal factor analysis was conducted to determine whether the changes in symptoms followed any consistent pattern. We observed that all three groups of symptoms tended to change in unison and independently from one another.

Conclusions
These results suggest that these three dimensions of psychopathology show different patterns of exacerbation and remission during the course of schizophrenia. This independent pattern of evolution suggests that these three dimensions should be studied further with respect to response to treatment, cognitive mechanisms, psychosocial correlates, and neural substrates.



Author Affiliations

From the Mental Health Clinical Research Center (Drs Arndt, Andreasen, Flaum, Miller, and Nopoulos) and the Departments of Preventive Medicine and Environmental Health (Dr Arndt) and Psychiatry (Drs Andreasen, Flaum, Miller, and Nopoulos), The University of Iowa Hospitals and Clinics, Iowa City.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anxiety Interacts With Expressed Emotion Criticism in the Prediction of Psychotic Symptom Exacerbation
Docherty et al.
Schizophr Bull 2009;0:sbp123v1-sbp123.
ABSTRACT | FULL TEXT  

Capturing the Ebb and Flow of Psychiatric Symptoms With Dynamical Systems Models
Odgers et al.
Am. J. Psychiatry 2009;166:575-582.
ABSTRACT | FULL TEXT  

Life Events and High-Trait Reactivity Together Predict Psychotic Symptom Increases in Schizophrenia
Docherty et al.
Schizophr Bull 2009;35:638-645.
ABSTRACT | FULL TEXT  

Clinical Course and Outcome of Schizophrenia in a Predominantly Treatment-Naive Cohort in Rural Ethiopia
Alem et al.
Schizophr Bull 2009;35:646-654.
ABSTRACT | FULL TEXT  

How Frequent is Chronic Multiyear Delusional Activity and Recovery in Schizophrenia: A 20-Year Multi-follow-up
Harrow and Jobe
Schizophr Bull 2008;0:sbn074v1-sbn074.
ABSTRACT | FULL TEXT  

Genetic Heterogeneity, Modifier Genes, and Quantitative Phenotypes in Psychiatric Illness: Searching for a Framework
Fanous and Kendler
Focus 2006;4:423.
ABSTRACT | FULL TEXT  

Anhedonia in Schizophrenia: A Review of Assessment Strategies
Horan et al.
Schizophr Bull 2006;32:259-273.
ABSTRACT | FULL TEXT  

The Structure of Negative Symptoms Within Schizophrenia: Implications for Assessment
Blanchard and Cohen
Schizophr Bull 2006;32:238-245.
ABSTRACT | FULL TEXT  

First-Episode Psychosis: Psychopathology, Quality of Life, and Functional Outcome
Malla and Payne
Schizophr Bull 2005;31:650-671.
ABSTRACT | FULL TEXT  

Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Andreasen et al.
Am. J. Psychiatry 2005;162:441-449.
ABSTRACT | FULL TEXT  

A 23-Year-Old Man With Schizophrenia
Goff
JAMA 2002;287:3249-3257.
FULL TEXT  

Relation of Familial Schizophrenia to Negative Symptoms But Not to the Deficit Syndrome
Malaspina et al.
Am. J. Psychiatry 2000;157:994-1003.
ABSTRACT | FULL TEXT  

Management of Negative Symptoms Among Patients With Schizophrenia Attending Multiple-Family Groups
Dyck et al.
Psychiatr. Serv. 2000;51:513-519.
ABSTRACT | FULL TEXT  

Longitudinal Study of Cognitive Function in First-Episode and Recent-Onset Schizophrenia
Gold et al.
Am. J. Psychiatry 1999;156:1342-1348.
ABSTRACT | FULL TEXT  

Empirical Validation of Primary Negative Symptoms: Independence From Effects of Medication and Psychosis
Kelley et al.
Am. J. Psychiatry 1999;156:406-411.
ABSTRACT | FULL TEXT  

Characterization of Psychotic Conditions: Use of the Domains of Psychopathology Model
Ratakonda et al.
Arch Gen Psychiatry 1998;55:75-81.
ABSTRACT | FULL TEXT  

Recent Advances in the Understanding of Negative Symptoms in Schizophrenia
Littrell and Littrell
J Am Psychiatr Nurses Assoc 1997;3:111-117.
ABSTRACT  

Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms
Andreasen et al.
Arch Gen Psychiatry 1995;52:341-351.
ABSTRACT  

Signs and Symptoms: What Can They Tell Us About the Clinical Course and Pathophysiologic Processes of Schizophrenia?
Lieberman
Arch Gen Psychiatry 1995;52:361-363.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.